Company
United StatesPublic company, NASDAQ: MESOMesoblast, Inc. (NASDAQ: MESO), New York, NY – FDA Inspections
Inspection records and compliance data for Mesoblast, Inc. in New York, New York. 1 FDA inspection on record, last inspected June 21, 2018. Publicly traded as NASDAQ: MESO.
Company Profile
This profile covers Mesoblast, Inc. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 21, 2018.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 21, 2018 | NAI | Biologics · Bioresearch Monitoring | 1058703 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Mesoblast, Inc.
Stock ticker
MESO
Exchange
NASDAQ
Share price
$14.09
Market cap
$1.8B
Price as of
November 6, 2026
FEI Number
3012677947
Address
505 5th Ave Fl 3, New York, New York 10017, United States
Country
United States
ID: f01b1b52-6055-498e-b024-44e07efb950b